Welcome to Vicept

Focused on creating products for use in the largest and
fastest growing sectors of the dermatology market.

vicept - n. from Latin vita- life; and receptus (recipere) - to take back

1. A privately held specialty biopharmaceutical start-up focused on the discovery and development of dermatologic applications for drugs which have been shown to affect the cutaneous adrenergic receptors.

2. A leader in the development of (∝)-adrenergic receptor technology for the treatment of diseases of the skin.

3. Company founded with the mission to develop the first effective topically-applied treatment for the erythema (skin redness) associated with rosacea.

Rosacea

Rosacea is a common, chronic condition of the skin that is estimated to affect over 16 million people in the United States and over 45 million people worldwide.

Read More

Actinic Purpura

Actinic Purpura ('solar' or 'Bateman's' Purpura), a condition of easy bruising of the skin in chronically sun-exposed areas (usually the forearms, back of the hands, legs), is a significant cosmetic concern for many older adults.

Read More

We are pursuing indications which include the treatment and prevention of a number of medical and cosmetic conditions including Actinic (Solar) Purpura and peri-procedural bruising of the skin.